Ortho Clinical Diagnostics to Participate in the 40th Annual J.P. Morgan Healthcare Conference
January 03, 2022 08:00 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced...
Ortho Clinical Diagnostics to Participate in the 4th Annual Evercore ISI HealthCONx Conference
November 23, 2021 08:00 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that members...
Ortho Clinical Diagnostics Reports Third Quarter 2021 Results
November 03, 2021 16:05 ET
|
Ortho-Clinical Diagnostics, Inc
Strong Revenue Growth Drives Financial Results Company Raises Fiscal 2021 Guidance Across all Key Metrics Highlights Third quarter revenue increased 15.8% to $522.5 million, or 14.3% in...
Ortho Clinical Diagnostics to Report Third Quarter 2021 Results on November 3, 2021
October 12, 2021 16:15 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it will...
Ortho Clinical Diagnostics Announces Closing of Secondary Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares
September 14, 2021 16:15 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world’s largest pure-play in vitro diagnostics companies, today...
Ortho Clinical Diagnostics Announces Pricing of Secondary Offering of Ordinary Shares
September 09, 2021 19:15 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world’s largest pure-play in vitro diagnostics companies, today...
Ortho Clinical Diagnostics Announces Secondary Offering of Ordinary Shares
September 07, 2021 16:21 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) (the “Company”), one of the world’s largest pure-play in vitro diagnostics companies, today...
Ortho Clinical Diagnostics to Participate in September Investor Conferences
September 03, 2021 09:00 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced...
Ortho Clinical Diagnostics Reports Second Quarter 2021 Results
August 04, 2021 16:05 ET
|
Ortho-Clinical Diagnostics, Inc
Strong Revenue Growth Drives Financial Results Company Raises Fiscal 2021 Guidance Across all Key Metrics RARITAN, N.J., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc...
Ortho Clinical Diagnostics to Report Second Quarter 2021 Results on August 4, 2021
July 23, 2021 09:00 ET
|
Ortho-Clinical Diagnostics, Inc
RARITAN, N.J., July 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it will report...